Article
The CYP2J2 G-50T polymorphism and myocardial infarction in patients with cardiovascular risk profile.
BMC cardiovascular disorders - 23 Dec 2008
Börgel Jan, Bulut Daniel, Hanefeld Christoph, Neubauer Horst, Mügge Andreas, Epplen Jörg T, Holland-Letz Tim, Spiecker Martin
Abstract excerpt
BACKGROUND: Cytochrome P450 (CYP) enzyme 2J2, an epoxygenase predominantly expressed in the heart, metabolizes arachidonic acid to biologically active eicosanoids. One of the CYP2J2 products, 11, 12-epoxyeicosatrienoic acid, has several vasoprotective effects. The CYP2J2-G-50T-promotor polymorphism decreases gene expression and is associated with coronary artery disease. This association supports the vascular...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
